Sulfasalazine USP from Canada
Sulfasalazine is a synthetic organo-sulfur compound used primarily as an anti-inflammatory drug for treating ulcerative colitis and rheumatoid arthritis. It features a sulfonamide group directly linked to carbon atoms, qualifying it as an organo-sulfur compound under heading 2930. Classified specifically under 2930.90.92.35 as a pharmaceutical drug.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.6096.3%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA Drug Master File and ensure Certificate of Analysis confirms USP purity standards for pharmaceutical import
• Provide detailed chemical composition and therapeutic claims documentation to avoid reclassification as a mixture
• Verify DEA scheduling status as it's non-controlled but requires accurate labeling to prevent delays